# Ophirex, Inc.

Canonical: https://abierto.us/vendors/ophirex-inc-w452wy5e2jq9

- UEI: W452WY5E2JQ9
- CAGE: 7JTR0
- Location: Corte Madera, CA
- Awards in window: 2 (2 transactions), $3,885,532 obligated, March 19, 2024 to September 5, 2025

## Awarding agencies

- Defense Health Agency: 2 awards, $3,885,532

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $3,885,532

## Competition

- Full and Open Competition After Exclusion of Sources: 2 awards

## Largest awards

- W81XWH22C0030 (definitive contract): $4,530,514, Army Med Res Acq Activity. Follow on Phase III Medical R&D SBIR for Project Titled Broad-Spectrum Snakebite Antidote Oral Product Development and IV Clinical Study. https://www.usaspending.gov/award/CONT_AWD_W81XWH22C0030_9700_-NONE-_-NONE-/
- W81XWH20C0066 (definitive contract): -$644,982, Army Med Res Acq Activity. Targeting Spla2 for Treatment of Acute Respiratory Distress Syndrome Associated with Sars-Cov-2. https://www.usaspending.gov/award/CONT_AWD_W81XWH20C0066_9700_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/ophirex-inc-w452wy5e2jq9.